ENTITY
Bristol Myers Squibb Co

Bristol Myers Squibb Co (BMY US)

226
Analysis
Health CareUnited States
Bristol-Myers Squibb Company is a global biopharmaceutical company. The Company develops, licenses, manufactures, markets, and sells pharmaceutical and nutritional products. Bristol-Myers Squibb products and experimental therapies address cancer, heart disease, HIV/AIDS, diabetes, rheumatoid arthritis, hepatitis, organ transplant rejection, and psychiatric disorders.
more
Refresh
18 Oct 2016 03:24

Could Blue-Chip Bristol-Myers Squibb's (NYSE: BMY) Shares Rise More than 40% by Early 2018?

Bristol-Myers Squibb (NYSE: BMY) common stock is trading close to 52-week lows after the failure of pivotal phase 3 trial of Opdivo (anti-PD1...

11 Oct 2016 16:59

Strike 2 in St Louis: Trump's Town Hall Trap

Before the Battle. Even before this key 2nd presidential debate in St Louis on October 9 (but October 10 Thai time), the press raised many issues....

01 Oct 2016 19:32

2016 US Elections Scenario Two: Donald Trump Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
210 Views
Share
01 Oct 2016 19:29

2016 US Elections Scenario One: Hillary Clinton Wins

A US election fought under moderately favourable economic conditions, with a Republican electorate divided and openly unhappy with its...

Logo
196 Views
Share
01 Oct 2016 19:07

On Trade, An Era Is Ending

Whatever the outcome of the US election, President Barack Obama's departure in early 2017 will present renewed challenges for Asia Pacific trade....

Logo
215 Views
Share
x